SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury
International Journal of Molecular Sciences · 25.04.2023 · 24 (9) · 7815
DOI: 10.3390/ijms24097815 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.04.2023. Verfasst von Isaac González-Soria und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Insufficiency, Chronic, Reperfusion Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Mexican Council of Science and Technology, the Universidad Nacional Autónoma de México, Mexican Council of Science and Technology (CONACyT).
Abstract (Originalsprache)
We previously showed that SerpinA3K is present in urine from rats and humans with acute kidney injury (AKI) and chronic kidney disease (CKD). However, the specific role of SerpinA3K during renal pathophysiology is unknown. To begin to understand the role of SerpinA3K on AKI, SerpinA3K-deficient (KOSA3) mice were studied 24 h after inducing ischemia/reperfusion (I/R) and compared to wild type (WT) mice. Four groups were studied: WT+S, WT+IR, KOSA3+S, and KOSA3+IR. As expected, I/R increased serum creatinine and BUN, with a GFR reduction in both genotypes; however, renal dysfunction was ameliorated in the KOSA3+IR group. Interestingly, the increase in UH2O2 induced by I/R was not equally seen in the KOSA3+IR group, an effect that was associated with the preservation of antioxidant enzymes’ mRNA levels. Additionally, FOXO3 expression was initially greater in the KOSA3 than in the WT group. Moreover, the increase in BAX protein level and the decrease in Hif1a and Vegfa induced by I/R were not observed in the KOSA3+IR group, suggesting that these animals have better cellular responses to hypoxic injury. Our findings suggest that SerpinA3K is involved in the renal oxidant response, HIF1α/VEGF pathway, and cell apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
- PECEM (MD/PhD), Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
ORCID-Profile: Isaac González-Soria, Axel D Soto-Valadez, Miguel Angel Martínez-Rojas, Juan Antonio Ortega-Trejo, Gerardo Gamba
Förderung
- the Mexican Council of Science and Technology
- the Universidad Nacional Autónoma de México
- Mexican Council of Science and Technology (CONACyT)
- Universidad Nacional Autónoma de México
Zitieren
APA
González-Soria, I., Soto-Valadez, A. D., Martínez-Rojas, M. A., Ortega-Trejo, J. A., Pérez-Villalva, R., Gamba, G., Sánchez-Navarro, A., & Bobadilla, N. A. (2023). SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury. International Journal of Molecular Sciences, 24(9), 7815. https://doi.org/10.3390/ijms24097815
Vancouver
González-Soria I, Soto-Valadez AD, Martínez-Rojas MA, Ortega-Trejo JA, Pérez-Villalva R, Gamba G, et al. SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury. International Journal of Molecular Sciences. 2023;24(9):7815. doi:10.3390/ijms24097815
BibTeX
@article{GonzlezSoria2023,
author = {González-Soria, Isaac and Soto-Valadez, Axel D and Martínez-Rojas, Miguel Angel and Ortega-Trejo, Juan Antonio and Pérez-Villalva, Rosalba and Gamba, Gerardo and Sánchez-Navarro, Andrea and Bobadilla, Norma A},
title = {SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {7815},
doi = {10.3390/ijms24097815}
}
EUVIMED